Found 13 matching trials
Evaluation of Safety and Feasibility of OGX-011 in Combination With 2nd-line Chemotherapy in Patients With HRPC PHASE2 This study is for patients with cancer of the prostate gland that has metas...
Show More Location
Tom Baker Cancer Centre
Learn More & Join Trial
A Clinical Study in Cancer Patients to Investigate the Potential Impact of Custirsen, on the Blood Levels of the Chemotherapeutic Drug, Paclitaxel, When Given Together as Part of a Treatment Regimen PHASE1 The primary goal of this study is to determine if custirsen has an effect o...
Show More Location
Teva Investigational Site 002
Learn More & Join Trial
Study of OGX-011 Given Prior to Radical Prostatectomy in Patients With Localized Prostate Cancer PHASE2 The purpose of this trial is to assess the effects of combined therapy with...
Show More Location
BC Cancer Agency and Vancouver General Hospital
Learn More & Join Trial
OGX-011 and Docetaxel in Treating Patients With Metastatic or Locally Recurrent Solid Tumors PHASE1 RATIONALE: OGX-011 may kill tumor cells by blocking some of the proteins th...
Show More Location
Multiple Locations
Learn More & Join Trial
Comparison of Cabazitaxel/Prednisone Alone or in Combination With Custirsen for 2nd Line Chemotherapy in Prostate Cancer PHASE3 This Phase 3 study has been designed to confirm that adding custirsen to ca...
Show More Location
Prostate Oncology Specialists
Learn More & Join Trial
A Study Evaluating the Pain Palliation Benefit of Adding Custirsen to Docetaxel Retreatment or Cabazitaxel as Second Line Therapy in Men With Metastatic Castrate Resistant Prostate Cancer (mCRPC) PHASE3 The purpose of this study is to determine if the addition of study drug (cu...
Show More Location
Multiple Locations
Learn More & Join Trial
Comparison of Docetaxel/Prednisone to Docetaxel/Prednisone in Combination With OGX-011 in Men With Prostate Cancer PHASE3 This Phase 3 study has been designed to confirm that adding custirsen to st...
Show More Location
Teva Investigational Site 100
Learn More & Join Trial
Docetaxel and Prednisone With/Out OGX-011 in Recurrent or Metastatic Prostate Cancer That Did Not Respond to Previous Hormone Therapy PHASE2 RATIONALE: Drugs used in chemotherapy, such as docetaxel and prednisone, wo...
Show More Location
University of Washington
Learn More & Join Trial
Hormone Therapy and OGX-011 Before Radical Prostatectomy in Treating Patients With Prostate Cancer PHASE1 RATIONALE: Androgens can stimulate the growth of prostate cancer cells. Dru...
Show More Location
British Columbia Cancer Agency - Vancouver Cancer Centre
Learn More & Join Trial
OGX-011 and Docetaxel in Treating Women With Locally Advanced or Metastatic Breast Cancer PHASE2 RATIONALE: Drugs used in chemotherapy, such as docetaxel, work in different...
Show More Location
British Columbia Cancer Agency - Centre for the Southern Interior
Learn More & Join Trial